Impaired flow-induced arterial remodeling in DOCA-salt hypertensive rats

7Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Arteries from young healthy animals respond to chronic changes in blood flow and blood pressure by structural remodeling. We tested whether the ability to respond to decreased (-90%) or increased (+100%) blood flow is impaired during the development of deoxycorticosterone acetate (DOCA)-salt hypertension in rats, a model for an upregulated endothelin-1 system. Mesenteric small arteries (MrA) were exposed to low blood flow (LF) or high blood flow (HF) for 4 or 7 weeks. The bioavailability of vasoactive peptides was modified by chronic treatment of the rats with the dual neutral endopeptidase (NEP)/endothelin- converting enzyme (ECE) inhibitor SOL1. After 3 or 6 weeks of hypertension, the MrA showed hypertrophic arterial remodeling (3 weeks: media cross-sectional area (mCSA): 10±1 × 10 3 to 17±2 × 10 3 μm 2; 6 weeks: 13±2 × 10 3 to 24±3 × 10 3 μm 2). After 3, but not 6, weeks of hypertension, the arterial diameter was increased (O: 385±13 to 463±14 μm). SOL1 reduced hypertrophy after 3 weeks of hypertension (mCSA: 6 × 10 3 ±1 × 10 3 μm 2). The diameter of the HF arteries of normotensive rats increased (O: 463±22 μm) but no expansion occurred in the HF arteries of hypertensive rats (O: 471±16 μm). MrA from SOL1-treated hypertensive rats did show a significant diameter increase (O: 419±13 to 475±16 μm). Arteries exposed to LF showed inward remodeling in normotensive and hypertensive rats (mean O between 235 and 290 μm), and infiltration of monocyte/macrophages. SOL1 treatment did not affect the arterial diameter of LF arteries but reduced the infiltration of monocyte/macrophages. We show for the first time that flow-induced remodeling is impaired during the development of DOCA-salt hypertension and that this can be prevented by chronic NEP/ECE inhibition. © 2012 The Japanese Society of Hypertension All rights reserved.

References Powered by Scopus

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

10685Citations
N/AReaders
Get full text

Physiological aspects of primary hypertension.

1684Citations
N/AReaders
Get full text

Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling

725Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Endothelin

616Citations
N/AReaders
Get full text

Macrophage depletion lowers blood pressure and restores sympathetic nerve α<inf>2</inf>-adrenergic receptor function in mesenteric arteries of DOCA-salt hypertensive rats

31Citations
N/AReaders
Get full text

Remodeling of arterial wall: Response to changes in both blood flow and blood pressure

20Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lemkens, P., Nelissen, J., Meens, M. J. P. M. T., Fazzi, G. E., Janssen, G. J. M., Debets, J. J. M., … De Mey, J. G. R. (2012). Impaired flow-induced arterial remodeling in DOCA-salt hypertensive rats. Hypertension Research, 35(11), 1093–1101. https://doi.org/10.1038/hr.2012.94

Readers over time

‘12‘14‘15‘16‘17‘20‘2102468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

40%

Researcher 2

40%

Professor / Associate Prof. 1

20%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 2

33%

Medicine and Dentistry 2

33%

Pharmacology, Toxicology and Pharmaceut... 1

17%

Nursing and Health Professions 1

17%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 2

Save time finding and organizing research with Mendeley

Sign up for free
0